Trials of anti-tuberculosis treatment in areas of high human immunodeficiency virus prevalence in sub-Saharan Africa

International Journal of Tuberculosis and Lung Disease

Volumn 4, Issue 11, 2000, Pages 998-1001

  Harries, A D ^a   Hargreaves, N J ^a   Kumwenda, J ^a   Kwanjana, J H ^a   Salaniponi, F M ^a  

^a British High Commission   (Malawi)

Author keywords

HIV infection; Trial of anti tuberculosis treatment

Indexed keywords

TUBERCULOSTATIC AGENT;

ADULT; AFRICA; ARTICLE; CASE REPORT; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION CONTROL; LUNG TUBERCULOSIS; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL;

ADULT; AFRICA SOUTH OF THE SAHARA; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ALGORITHMS; ANTITUBERCULAR AGENTS; HUMANS; MALE; PREVALENCE; TUBERCULOSIS;

EID: 0033763610     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. The course of fever during treatment of pulmonary tuberculosis
2. Analysis of the subsiding of fever of 187 tuberculosis patients after treatment
3. Tuberculosis in Africa: Clinical presentation and management
4. Respiratory tuberculosis
5. Contribution of tuberculosis to slim disease in Africa
6. Fatal Mycobacterium tuberculosis bloodstream infections in febrile hospitalized adults in Dares Salaam, Tanzania
7. Unrecognised Mycobacterium tuberculosis bacteraemia among hospital inpatients in less developed countries
8. Miliary tuberculosis: Rapid diagnosis, hematologic abnormalities, and outcome in 109 treated adults
9. An approach to the problems of diagnosing and treating adult smear-negative pulmonary tuberculosis in high-HIV-prevalence settings in sub-Saharan Africa
10. Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection